Search research articles
Contact Us
Filters
Showing results (61-70 of 68) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 68 results.
Cancers
|
April 30, 2021
Immune Monitoring during Therapy Reveals Activitory and Regulatory Immune Responses in High-Risk Neuroblastoma
Celina L Szanto, Annelisa M Cornel, Sara M Tamminga, et al.
Journal for Immunotherapy of Cancer
|
July 21, 2023
IgA antibody immunotherapy targeting GD2 is effective in preclinical neuroblastoma models
Marjolein C Stip, Mitchell Evers, Maaike Nederend, et al.
Journal for Immunotherapy of Cancer
|
December 15, 2022
Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switch
Annelisa M Cornel, Ester Dunnebach, Damon A Hofman, et al.
Nature Cancer
|
September 22, 2022
Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypes
Satyaki Sengupta, Sanjukta Das, Angela C Crespo, et al.
Journal for Immunotherapy of Cancer
|
March 22, 2024
Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1
Annelisa M Cornel, Loutje van der Sman, Jip T van Dinter, et al.
Nature Cancer
|
January 6, 2026
De novo H3.3K27M-altered diffuse midline glioma in human brainstem organoids to dissect GD2 CAR T cell function
Nils Bessler, Amber K L Wezenaar, Hendrikus C R Ariese, et al.
Nature Biotechnology
|
July 25, 2022
Uncovering the mode of action of engineered T cells in patient cancer organoids
Johanna F Dekkers, Maria Alieva, Astrid Cleven, et al.
Cancer Cell
|
January 5, 2024
Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy
Judith Wienke, Lindy L Visser, Waleed M Kholosy, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 68) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 68 results.
Cancers
|
April 30, 2021
Immune Monitoring during Therapy Reveals Activitory and Regulatory Immune Responses in High-Risk Neuroblastoma
Celina L Szanto, Annelisa M Cornel, Sara M Tamminga, et al.
Journal for Immunotherapy of Cancer
|
July 21, 2023
IgA antibody immunotherapy targeting GD2 is effective in preclinical neuroblastoma models
Marjolein C Stip, Mitchell Evers, Maaike Nederend, et al.
Journal for Immunotherapy of Cancer
|
December 15, 2022
Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switch
Annelisa M Cornel, Ester Dunnebach, Damon A Hofman, et al.
Nature Cancer
|
September 22, 2022
Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypes
Satyaki Sengupta, Sanjukta Das, Angela C Crespo, et al.
Journal for Immunotherapy of Cancer
|
March 22, 2024
Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1
Annelisa M Cornel, Loutje van der Sman, Jip T van Dinter, et al.
Nature Cancer
|
January 6, 2026
De novo H3.3K27M-altered diffuse midline glioma in human brainstem organoids to dissect GD2 CAR T cell function
Nils Bessler, Amber K L Wezenaar, Hendrikus C R Ariese, et al.
Nature Biotechnology
|
July 25, 2022
Uncovering the mode of action of engineered T cells in patient cancer organoids
Johanna F Dekkers, Maria Alieva, Astrid Cleven, et al.
Cancer Cell
|
January 5, 2024
Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy
Judith Wienke, Lindy L Visser, Waleed M Kholosy, et al.
Page
of 7